Publications 38 Datasets 392.5k Experiments 4.7k

Explore

Filters: partial ✕ Medicine ✕ 1 ✕ clear all

38 matching publication(s)

Publication	Journal	Year	Score	Verdict
Integrated multi-omics analysis combined with clinical validation reveals that HLA-DRB5 and ODAPH are causal risk genes for keratoconus. PMID 41803193	Sci Rep	2026	64	L1 64/100
Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancer. PMID 41550766	iScience	2025	50	L1 50/100
Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma. PMID 41387425	Nat Commun	2025	66	L1 66/100
Advances in genomic and pharmacokinetic profiling for clinical stratification of metastatic breast cancer. PMID 41369820	Discov Oncol	2025	59	L1 59/100
Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events. PMID 41254329	Commun Med (Lond)	2025	71	L1 71/100
Spatial-reprogramming derived GPNMB+ macrophages interact with COL6A3+ fibroblasts to enhance vascular fibrosis in PMID 41174767	Genome Med	2025	64	L1 64/100
Interpretable artificial intelligence based on immunoregulation-related genes predicts prognosis and immunotherapy response in lung adenocarcinoma. PMID 41048340	Front Bioinform	2025	71	L1 71/100
Positive Relationships between Intraocular Pressure and Thyroid Function in Graves' Ophthalmopathy: A Three-Aspect Evidence Analysis. PMID 40992768	Yonsei Med J	2025	68	L1 68/100
Targeted and personalized immunotherapy in lung adenocarcinoma: single-cell RNA sequencing of MAFF+ tumor cells and the therapeutic potential PMID 40936936	Front Immunol	2025	71	L1 71/100
Molecular subtype of recurrent implantation failure reveals distinct endometrial etiology of female infertility. PMID 40660214	J Transl Med	2025	68	L1 68/100
Comprehensive bioinformatics analysis and experimental verification identify mitochondrial gene Dgat2 as a novel therapeutic biomarker for myocardial ischemia-r PMID 40510478	Front Endocrinol (Lausanne)	2025	64	L1 64/100
Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer. PMID 40197136	BMC Cancer	2025	59	L1 59/100
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses. PMID 40128415	Breast Cancer	2025	71	L1 71/100
Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers. PMID 39779736	Sci Rep	2025	74	L1 74/100
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer. PMID 39572705	Commun Biol	2024	68	L1 68/100
A platelet-related signature for predicting the prognosis and immunotherapy benefit in bladder cancer based on machine learning combinations. ⚑ PMID 39280688	Transl Androl Urol	2024	51	L1 51/100 ⚑
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials. PMID 39090192	NPJ Precis Oncol	2024	50	L1 50/100
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). PMID 38897205	Cell Rep Med	2024	72	L1 72/100
The molecular landscape of sepsis severity in infants: enhanced coagulation, innate immunity, and T cell repression. PMID 38817614	Front Immunol	2024	50	L1 50/100
Developing a novel immune infiltration-associated mitophagy prediction model for amyotrophic lateral sclerosis using bioinformatics strategies. PMID 38601155	Front Immunol	2024	71	L1 71/100
Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy. PMID 38504986	Front Immunol	2024	73	L1 73/100
Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid Leukemia Reveals a Signature Predicting Survival and Immunotherapy. PMID 38322112	Int J Clin Pract	2024	71	L1 71/100
Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer. PMID 38076064	Heliyon	2023	71	L1 71/100
Application of Machine Learning in Predicting Hepatic Metastasis or Primary Site in Gastroenteropancreatic Neuroendocrine Tumors. ⚑ PMID 37887568	Curr Oncol	2023	59	L1 59/100 ⚑
A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study. ⚑ PMID 37852185	Cell Rep Med	2023	65	65/100 ⚑
Zebrafish functional xenograft vasculature platform identifies PF-502 as a durable vasculature normalization drug. PMID 37680473	iScience	2023	70	L1 70/100
Identification of common genetic characteristics of rheumatoid arthritis and major depressive disorder by bioinformatics analysis and machine learning. ⚑ PMID 37415981	Front Immunol	2023	58	L1 58/100 ⚑
Clinical and molecular correlation defines activity of physiological pathways in life-sustaining kidney xenotransplantation. PMID 37311769	Nat Commun	2023	69	L1 69/100
Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma. PMID 37161060	Sci Rep	2023	73	L1 73/100
Artificial intelligence-guided discovery of gastric cancer continuum. PMID 36692601	Gastric Cancer	2023	71	L1 71/100
Identification of intrinsic genes across general hypertension, hypertension with left ventricular remodeling, and uncontrolled hypertension. PMID 36277786	Front Cardiovasc Med	2022	73	L1 73/100
Identifying Molecular Subtypes and 6-Gene Prognostic Signature Based on Hypoxia for Optimizing Targeted Therapies in Non-Small Cell Lung Cancer. PMID 35509605	Int J Gen Med	2022	59	L1 59/100
Predicting Bone Metastasis Using Gene Expression-Based Machine Learning Models. PMID 34858485	Front Genet	2021	62	L1 62/100
Gene Set Enrichment Analysis Reveals Individual Variability in Host Responses in Tuberculosis Patients. PMID 34421903	Front Immunol	2021	71	71/100
Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer. ⚑ PMID 33986754	Front Immunol	2021	51	L1 51/100 ⚑
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy. PMID 33723257	Nat Commun	2021	70	L1 70/100
Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel. PMID 33138797	BMC Cancer	2020	72	L1 72/100
Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. PMID 31443728	Genome Med	2019	68	L1 68/100